Hutchison China Meditech Ltd (LSE:HCM) - Share price


Stock Report

Hutchison China Meditech Ltd HCM

Last Price
GBX335.00

Day Change
-5.00|-1.47%

As of 12/12/2019
09:00:19 GMT | GBX
Minimum 15 Minutes Delay.

Last Close340.00p
Day Range334.40 - 342.00
Mkt Cap2.27Bil
52-Wk Range260.50 - 531.00
Yield %-
ISINKYG4672N1198
Volume3,869
P/E14.93
P/S10.40
P/CF-68.37

Share Price

Total Returns 11/12/2019

 Chg (%)  
More ...
Hutchison China Meditech Ltd-5.56 
FTSE 100 TR GBP-1.18
 
Financials
201620172018
More ...
Income Statement
Turnover216.08241.20214.11
Operating Profit-46.70-53.42-92.64
Net Profit14.56-22.96-71.29
Reported EPS0.02-0.04-0.11
Balance Sheet
Current Assets167.38432.20370.54
Non Current Assets175.06165.74161.58
Total Assets342.44597.93532.12
Current Liabilities95.12104.6085.48
Total Liabilities---
Total Equity204.06484.97412.26
Cash Flow
Operating Cash Flow-9.57-8.94-32.85
Net Change in Cash49.273.472.67

Regulatory News

DateAuthor Headline
18/12/2012Alanna Petroff Fund Managers’ Favourites: Illuminating Investments
VIDEO: Mark Slater from Slater Investments discusses his three favourite equity picks, including a company that is a leader in LED lighting technology
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
22/03/2019Transfer inChristian Hogg0.004,1170.00
22/03/2019Transfer inJohnny Cheng Chig FUNG0.001,2700.00
22/03/2019Transfer inDr. Weiguo Su0.001,5040.00

Company Profile

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases.

Sector

Drug Manufacturers - General

Index

FTSE AIM 100 ,FTSE AIM All-Share

Next Event 11/03/2020

Final Results
Ratios
Comp
More ...
PER (E)15.11
Div Yld (E)0.00
PEG (E)0.00
ROCE-19.18
Op Mrgn-0.43
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Graeme Allan Jack
Non-Executive DirectorDan Eldar
Non-Executive DirectorMr Paul Rutherford Carter
Non-Executive Director, Company SecretaryEdith Shih
Executive Director, ChairmanMr. Chi Keung Simon To
Executive Director, Chief Executive OfficerChristian Hogg
Executive Director, Chief Financial OfficerJohnny Cheng Chig FUNG
Non-Executive DirectorDr. Karen Jean Ferrante M.D.
Executive Director, Chief Scientific OfficerDr. Weiguo Su
Non-Executive DirectorProfessor Shu Kam Tony Mok
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.